United States

Profile: Bioanalytical Systems Inc (BASI.O)

BASI.O on Consolidated Issue listed on NASDAQ Capital Market

30 Sep 2016
Change (% chg)

$-0.02 (-1.71%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bioanalytical Systems, Inc., incorporated on July 17, 1975, is an international contract research organization providing drug discovery and development services and analytical instruments. The Company's clients and partners include pharmaceutical, biotechnology, academic and government organizations. The Company derives its revenues from sales of its research services and drug development tools. The Company supports the preclinical and clinical development needs of researchers and clinicians for small molecule and biomolecule drug candidates. The Company's principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic research from small start-up biotechnology companies to many of the global pharmaceutical companies. The Company operates in two business segments: contract research services and research products, both of which addresses the bioanalytical, preclinical, and clinical research needs of drug developers.


This segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. Product Characterization, Method Development, and Validation: Analytical methods, primarily performed in West Lafayette, Indiana, determine potency, purity, chemical composition, structure, and physical properties of a compound. Bioanalytical Testing: The Company analyzes specimens from preclinical and clinical trials to measure drug and metabolite concentrations in complex biological matrices. Bioanalysis is performed at its facilities in West Lafayette, Indiana. Stability Testing: The Company tests stability of drug substances and formulated drug products, and maintains storage facilities in West Lafayette, Indiana. In Vivo Pharmacology: The Company provides preclinical in vivo sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels through, and is metabolized in living systems. Those services are performed in customized facilities in West Lafayette and Evansville, Indiana using its robotic Culex Automated Pharmacology System. Preclinical and Pathology Services: The Company provides pharmacokinetic and safety testing in studies ranging from acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in its Evansville, Indiana site.

Research Products

This segment designs, develops, manufactures, and markets in vivo sampling systems and accessories (including disposables, training, and systems qualification); physiology monitoring tools; and liquid chromatography and electrochemistry instruments platforms. Analytical Products: The analytical products consist of the Company’s liquid chromatographic and electrochemical instruments with associated accessories. The critical component of these products is the Epsilon electrochemical platform. The market is principally academic institutions and industrial research companies. In vivo Sampling Products: The in vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments. These are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals. The Culex products offer reduction in test model use and comparable reduction in labor. The line also includes in vivo sampling devices sold to drug developers and medical research centers to assist in the study of various medical conditions, including stroke, depression, Alzheimer’s and Parkinson’s diseases, diabetes, and osteoporosis. Vetronics’ Products: The Vetronics’ products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram), and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics.

The Company competes with Covance, Inc.; Pharmaceutical Product Development, Inc.; Charles River Laboratories, Inc., and Quintiles Transnational Holdings, Inc.

Company Address

Bioanalytical Systems Inc

2701 Kent Ave
WEST LAFAYETTE   IN   47906-1350
P: +1317.4634527
F: +1765.7426699

Company Web Links